OncoSec Medical Performance

The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and OncoSec Medical are completely uncorrelated.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days OncoSec Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, OncoSec Medical is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Begin Period Cash Flow46 M
Total Cashflows From Investing Activities-244.9 K
  

OncoSec Medical Relative Risk vs. Return Landscape

If you would invest (100.00) in OncoSec Medical on November 1, 2025 and sell it today you would earn a total of  100.00  from holding OncoSec Medical or generate -100.0% return on investment over 90 days. OncoSec Medical is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than OncoSec, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

OncoSec Medical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of OncoSec Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for OncoSec Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
OncoSec Medical is not yet fully synchronised with the market data
OncoSec Medical has some characteristics of a very speculative penny stock
OncoSec Medical has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (34.18 M) with profit before overhead, payroll, taxes, and interest of 0.
OncoSec Medical currently holds about 19.48 M in cash with (32.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.5.
Roughly 28.0% of the company outstanding shares are owned by corporate insiders

OncoSec Medical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of OncoSec Stock often depends not only on the future outlook of the current and potential OncoSec Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. OncoSec Medical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.8 M
Cash And Short Term Investments12.3 M

OncoSec Medical Fundamentals Growth

OncoSec Stock prices reflect investors' perceptions of the future prospects and financial health of OncoSec Medical, and OncoSec Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on OncoSec Stock performance.

Things to note about OncoSec Medical performance evaluation

Checking the ongoing alerts about OncoSec Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for OncoSec Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
OncoSec Medical is not yet fully synchronised with the market data
OncoSec Medical has some characteristics of a very speculative penny stock
OncoSec Medical has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (34.18 M) with profit before overhead, payroll, taxes, and interest of 0.
OncoSec Medical currently holds about 19.48 M in cash with (32.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.5.
Roughly 28.0% of the company outstanding shares are owned by corporate insiders
Evaluating OncoSec Medical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate OncoSec Medical's stock performance include:
  • Analyzing OncoSec Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether OncoSec Medical's stock is overvalued or undervalued compared to its peers.
  • Examining OncoSec Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating OncoSec Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of OncoSec Medical's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of OncoSec Medical's stock. These opinions can provide insight into OncoSec Medical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating OncoSec Medical's stock performance is not an exact science, and many factors can impact OncoSec Medical's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in OncoSec Stock

If you are still planning to invest in OncoSec Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoSec Medical's history and understand the potential risks before investing.
Transaction History
View history of all your transactions and understand their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals